(Q28083185)

main subject

hepatocellular carcinoma

1 reference

4 November 2019

1 reference

4 November 2019

yttrium radioisotopes

1 reference

4 November 2019

1 reference

2

Yan Rolland

1 reference

Etienne Garin

1

1 reference

Sophie Laffont

series ordinal

3

1 reference

Julien Edeline

series ordinal

4

1 reference

language of work or name

1 reference

March 2016

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

1 March 2016

2 references

3 April 2019

4 November 2019

3 references

3 April 2019

4 November 2019

43

1 reference

issue

3

1 reference

page(s)

559-75

1 reference

Creative Commons Attribution 4.0 International

copyright license

2 references

Europe PubMed Central

3 April 2019

Europe PubMed Central

on focus list of Wikimedia project

4 November 2019

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Relationship of 99mtechnetium labelled macroaggregated albumin (99mTc-MAA) uptake by colorectal liver metastases to response following Selective Internal Radiation Therapy (SIRT)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4731431

Personalized predictive lung dosimetry by technetium-99m macroaggregated albumin SPECT/CT for yttrium-90 radioembolization.

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4731431

Post-radioembolization yttrium-90 PET/CT - part 2: dose-response and tumor predictive dosimetry for resin microspheres

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4731431

Post-radioembolization yttrium-90 PET/CT - part 1: diagnostic reporting

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4731431

Boosted selective internal radiation therapy with 90Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: a new personalized promising concept

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4731431

SIRT of liver metastases: physiological and pathophysiological considerations

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4731431

Radioembolization for hepatocellular carcinoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4731431

Need, feasibility and convenience of dosimetric treatment planning in liver selective internal radiation therapy with (90)Y microspheres: the experience of the National Tumor Institute of Milan

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4731431

Research reporting standards for radioembolization of hepatic malignancies.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4731431

Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4731431

Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4731431

Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: the tumor selectivity of the treatment as a function of tumor to liver flow ratio

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4731431

Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: a risk-stratification analysis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4731431

The human liver after radiation injury. A form of veno-occlusive disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4731431

A dosimetric treatment planning strategy in radioembolization of hepatocarcinoma with 90Y glass microspheres

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4731431

Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4731431

Biocompatibility, inflammatory response, and recannalization characteristics of nonradioactive resin microspheres: histological findings.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4731431

Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4731431

Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer

2 June 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3157-8

Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3157-8

Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3157-8

Patient selection and activity planning guide for selective internal radiotherapy with yttrium-90 resin microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3157-8

Effectiveness of quantitative MAA SPECT/CT for the definition of vascularized hepatic volume and dosimetric approach: phantom validation and clinical preliminary results in patients with complex hepatic vascularization treated with yttrium-90-label

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3157-8

Efficacy and toxicity related to treatment of hepatocellular carcinoma with 90Y-SIR spheres: radiobiologic considerations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3157-8

Radioembolisation with 90Y-microspheres: dosimetric and radiobiological investigation for multi-cycle treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3157-8

99mTc-macroaggregated albumin poorly predicts the intrahepatic distribution of 90Y resin microspheres in hepatic radioembolization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3157-8

Dosimetry based on 99mTc-macroaggregated albumin SPECT/CT accurately predicts tumor response and survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microspheres: preliminary results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3157-8

Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3157-8

First experience of hepatic radioembolization using microspheres labelled with yttrium-90 (TheraSphere): practical aspects concerning its implementation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3157-8

Incidence of radiation pneumonitis after hepatic intra-arterial radiotherapy with yttrium-90 microspheres assuming uniform lung distribution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3157-8

Lung dose calculation with SPECT/CT for ⁹⁰Yittrium radioembolization of liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3157-8

Evaluation of the response to selective internal radiation therapy in patients with hepatocellular cancer according to pretreatment (99m)Tc-MAA uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3157-8

Personalized dosimetry with intensification using 90Y-loaded glass microsphere radioembolization induces prolonged overall survival in hepatocellular carcinoma patients with portal vein thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3157-8

Quantitative comparison of yttrium-90 (90Y)-microspheres and technetium-99m (99mTc)-macroaggregated albumin SPECT images for planning 90Y therapy of liver cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3157-8

Prognostic utility of 90Y radioembolization dosimetry based on fusion 99mTc-macroaggregated albumin-99mTc-sulfur colloid SPECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3157-8

Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3157-8

Liver disease induced by radioembolization of liver tumors: description and possible risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3157-8

Radiation Segmentectomy: A Novel Approach to Increase Safety and Efficacy of Radioembolization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3157-8

Internal pair production of 90Y permits hepatic localization of microspheres using routine PET: proof of concept.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3157-8

Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: A phase 2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3157-8

The low hepatic toxicity per Gray of 90Y glass microspheres is linked to their transport in the arterial tree favoring a nonuniform trapping as observed in posttherapy PET imaging.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4731431

Influence of time delay on the estimated lung shunt fraction on 99mTc-labeled MAA scintigraphy for 90Y microsphere treatment planning.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4731431

(⁹⁹m)Tc-MAA overestimates the absorbed dose to the lungs in radioembolization: a quantitative evaluation in patients treated with ¹⁶⁶Ho-microspheres

27 November 2018

1 reference

12 December 2020

Hepatic toxicity after radioembolization of the liver using (90)Y-microspheres: sequential lobar versus whole liver approach

1 reference

12 December 2020

Radioembolisation of hepatocellular carcinoma patients using ⁹⁰Y-labelled microspheres: towards a diffusion of the technique?

1 reference

12 December 2020

Predictive value of intratumoral 99mTc-macroaggregated albumin uptake in patients with colorectal liver metastases scheduled for radioembolization with 90Y-microspheres

1 reference

12 December 2020

Radiation pneumonitis after selective internal radiation treatment with intraarterial 90Yttrium-microspheres for inoperable hepatic tumors

1 reference

12 December 2020

Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancer

1 reference

12 December 2020

Measuring lung shunting in hepatocellular carcinoma with intrahepatic-arterial technetium-99m macroaggregated albumin

1 reference

12 December 2020

Manipulation of experimental rat and rabbit liver tumor blood flow with angiotensin II

1 reference

12 December 2020

Image-guided personalized predictive dosimetry by artery-specific SPECT/CT partition modeling for safe and effective 90Y radioembolization

1 reference

12 December 2020

Effect of angiotensin II on blood flow in the transplanted sheep squamous cell carcinoma

1 reference

12 December 2020

Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support

1 reference

12 December 2020

The importance of scatter correction for the assessment of lung shunting prior to yttrium-90 radioembolization therapy

1 reference

12 December 2020

Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres

1 reference

12 December 2020

10.1007/S00259-015-3157-8

Identifiers

DOI

0 references

1 reference

PubMed publication ID

26338177

1 reference